VA plans to double its electronic health record rollout in 2027 as federal auditors wait for the records to show the math ...
Oracle's AI opportunity is hard to ignore, but financing that growth comes at a price. I examine the numbers, risks, and ...
Oracle stock has been trading under a similar cloud of worry surrounding its own use of debt. The company has jumped ...
Learn what an oracle deviation threshold means, how it works, and what triggers new blockchain price updates during market ...
When Oracle first announced its plans in 2021, the promise was thousands of high-paying jobs and a major investment in ...
Oracle stock remains a "Buy," but AI and regulatory risks cloud its outlook. Here's what investors need to know about ORCL ...
AI-driven Oracle Cloud Infrastructure backlog is significant but concentrated, with half tied to OpenAI. Find out why ORCL ...
This article is the Japanese version of a post published on STEALIEN's Korean technical blog in December 2022. It introduces ...
Key TakeawaysOracle shares rose 5% after pricing the $20 billion stock and bond sale its own cap allowed through fiscal 2030. About 86 million new shares and $10 billion of 7%-8.
Oracle spent its way into negative free cash flow territory and watched its stock lose half its value, but at its Las Vegas investor day it drew a hard line on future borrowing and put a specific date ...
AstraZeneca AZN0.37%increase; up pointing triangle said it is teaming up with Oracle ORCL-0.99%decrease; down pointing triangle to refine clinical research, in the latest artificial-intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results